Cytoplasmic gelsolin in pheochromocytoma-12 cells forms a complex with amyloid beta-protein

NeuroReport

Volumn 19, Issue 4, 2008, Pages 463-466

  Ji, Lina ^a   Chauhan, Abha ^a   Chauhan, Ved ^a  

^a NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

Author keywords

Amyloid protein; Complex; Gelsolin; Hydrogen peroxide

Indexed keywords

AMYLOID BETA PROTEIN; GELSOLIN; HYDROGEN PEROXIDE;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; CELL LYSATE; CYTOPLASM; GENE EXPRESSION; IMMUNOPRECIPITATION; NONHUMAN; PHEOCHROMOCYTOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; RAT; TRANSGENE;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; BRAIN; CYTOPLASM; GELSOLIN; HYDROGEN PEROXIDE; MACROMOLECULAR SUBSTANCES; NEURONS; OXIDANTS; OXIDATIVE STRESS; PC12 CELLS; PROTEIN BINDING; PROTEIN STRUCTURE, QUATERNARY; RATS; SENILE PLAQUES;

EID: 39749137459     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/WNR.0b013e3282f5f79a     Document Type: Article

References (25)

1. Wisniewski HM, Wegiel J, Kotula L. Some neuropathology aspects of Alzheimer's disease and its relevance to other disciplines. Neuropathol Appl Neurobiol 1996; 22:3-11.
2. Glenner GG. Alzheimer's disease: the commonest form of amyloidosis. Arch Pathol Lab Med 1983; 107:281-282.
3. Knauer MF, Soreghan B, Burdick D, Kosmoski J, Glabe CG. Intracellular accumulation and resistance to degradation of the Alzheimer amyloid A4/beta protein. Proc Natl Acad Sci U S A 1992; 89:7437-7441.
4. Glabe C. Intracellular mechanisms of amyloid accumulation and pathogenesis in Alzheimer's disease. J Mol Neurosci 2001; 17:137-145.
5. Stossel TP. Actin-membrane interactions in eukaryotic mammalian cells. In: Hoffman JF, Giebisch G, editors. Current topics in membranes and transport. New York: New York Academic Press; 1990. pp. 97-107.
6. Janmay PA. Phosphoinositides and calcium as regulators of cellular actin assembly and disassembly. Annu Rev Physiol 1994; 56:169-191.
7. Kwiatkowski DJ, Mehl R, Yin HL. Genomic organization and biosynthesis of secreted and cytoplasmic forms of gelsolin. J Cell Biol 1988; 106:375-384.
8. Yin HL, Kwiatkowski DJ, Mole JE, Cole FS. Structure and biosynthesis of cytoplasmic and secreted variants of Gelsolin. J Biol Chem 1984; 259:5271-5276.
9. Wen D, Corina K, Chow EP, Miller S, Janmey PA, Pepinsky RB. The plasma and cytoplasmic forms of human gelsolin differ in disulfide structure. Biochemistry 1996; 35:9700-9709.
10. Kothakota S, Azuma T, Reinhard C, Klippel A, Tang J, Chu K, McGarry TJ, et al. Caspase-3-generated fragment of gelsolin: effector of morphological change in apoptosis. Science 1997; 278:294-298.
11. Kusano H, Shimizu S, Koya RC, Fujita H, Kamada S, Kuzumaki N, Tsujimoto Y. Human gelsolin prevents apoptosis by inhibiting apoptotic mitochondrial changes via closing VDAC. Oncogene 2000; 19:4807-4814.
12. Asch HL, Head K, Dong Y, Natoli F, Winston JS, Connolly JL, et al. Widespread loss of gelsolin in breast cancers of humans, mice, and rats. Cancer Res 1996; 56:4841-4845.
13. Kuzumaki N, Fujita H, Tanaka M, Sakai N, Ohtsu M. Tumor suppressive function of gelsolin. In: Maruta HK, Kohama K, editors. G proteins, cytoskeleton and cancer. Austin, Texas: RG Landes Company; 1998. pp. 121-131.
14. Prasad SC, Thraves PJ, Dritschilo A, Kuettel MR. Protein expression changes associated with radiation-induced neoplastic progression of human prostate epithelial cells. Electrophoresis 1997; 18:629-637.
15. Dosaka-Akita H, Hommura F, Fujita H, Kinoshita I, Nishi M, Morikawa T, et al. Frequent loss of gelsolin expression in non-small cell lung cancers of heavy smokers. Cancer Res 1998; 58:322-327.
16. Maury CP, Sletten K, Totty N, Kangas H, Liljestrom M. Identification of the circulating amyloid precursor and other gelsolin metabolites in patients with G654A mutation in the gelsolin gene (Finnish familial amyloidosis): pathogenetic and diagnostic implications. Lab Invest 1997; 77:299-304.
17. Chauhan VPS, Ray I, Chauhan A, Wisniewski HM. Binding of gelsolin, a secretory protein to amyloid β-protein. Biochem Biophys Res Commun 1999; 258:241-246.
18. Ray I, Chauhan A, Wegiel J, Chauhan VPS. Gelsolin inhibits the fibrillization of amyloid beta-protein, and also defibrillizes its preformed fibrils. Brain Res 2000; 853:344-351.
19. Matsuoka Y, Saito M, LaFrancois J, Saito M, Gaynor K, Olm V, et al. Novel therapeutic approach for the treatment of Alzheimer's disease by peripheral administration of agents with an affinity to beta-amyloid. J Neurosci 2003; 23:29-33.
20. Hirko AC, Meyer EM, King MA, Hughes JA. Peripheral transgene expression of plasma gelsolin reduces amyloid in transgenic mouse models of Alzheimer's disease. Mol Ther 2007; 5:1623-1629.
21. Yuyama K, Yamamoto N, Yanagisawa K. Chloroquine-induced endocytic pathway abnormalities: cellular model of GM1 ganglioside-induced Abeta fibrillogenesis in Alzheimer's disease. FEBS Lett 2006; 580:6972-6976.
22. Singh SS, Chauhan A, Murakami N, Chauhan VPS. Profilin and gelsolin stimulate phosphatidylinositol 3-kinase activity. Biochemistry 1996; 35:16544-16549.
23. Jang JH, Surh YJ. Possible role of NF-kappaB in Bcl-X(L) protection against hydrogen peroxide-induced PC12 cell death. Redox Rep 2004; 9:343-348.
24. Azuma T, Koths K, Flanagan L, Kwiatkowski DJ. Gelsolin in complex with phosphatidylinositol 4,5-bisphosphate inhibits caspase-3 and -9 to retard apoptotic progression. J Biol Chem 2000; 275:3761-3766.
25. Necula M, Kayed R, Milton S, Glabe CG. Small molecule inhibitors of aggregation indicate that amyloid beta oligomerization and fibrillization pathways are independent and distinct. J Biol Chem 2007; 282:10311-10324.